OPENPediatrics cover image

Immunoparalysis and the Future of Personalized Immunotherapy for Critically Ill Children by M. Hall

OPENPediatrics

00:00

Immunoparalysis Sampling, Biomarkers, and Treatment Eligibility in Pediatric Sepsis

Exploring the use of biomarkers in determining inflammation severity and eligibility criteria for GMCSF and Anakinra trials to tailor treatments for children with immunoparalysis, emphasizing the importance of real-time immunofenotyping for personalized care.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app